new rapid-acting insulin analog called NovoRapid (insulin aspart)
You'll hear about a new rapid-acting insulin analog called NovoRapid (insulin aspart).
Novo Nordisk is now marketing it in the U.S. under the name Novolog. NovoRapid will be available in Canada early next year.
Think of it as similar to Humalog (insulin lispro).
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote